|
| Section2 = }} 2CBFly-NBOMe (NBOMe-2C-B-FLY, Cimbi-31) is a compound indirectly derived from the phenethylamine hallucinogen 2C-B, and related to benzodifurans like 2C-B-FLY and ''N''-benzylphenethylamines like 25I-NBOMe. It was discovered in 2002, and further researched by Ralf Heim at the Free University of Berlin, and subsequently investigated in more detail by a team at Purdue University led by David E. Nichols. It acts as a potent partial agonist for the 5HT2A serotonin receptor subtype.〔 〕 ==Legality== 2CBFly-NBOMe is a controlled substance in Vermont as of January 2016.〔(【引用サイトリンク】 title=Regulated Drugs Rule )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「2CBFly-NBOMe」の詳細全文を読む スポンサード リンク
|